Polyphenolic antioxidant (–)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent
Gianfranco Fassina+5 more
openalex +1 more source
New Advances in Anti-HIV-1 Strategies Targeting the Assembly and Stability of Capsid Protein. [PDF]
Zhang C, Li B, Li J, Zhang H, Wu Y.
europepmc +1 more source
EVALUATION OF INDOLE-2-CARBOXYLIC ACID ESTERS AS ANTI-HIV AGENTS
Süreyya Ölgen, Doğu Nebioğlu
openalex +1 more source
A competing risk analysis of predictors of time to lost to follow-up among adults with TB/HIV coinfection in Bahir Dar. [PDF]
Demelash R+6 more
europepmc +1 more source
STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma. [PDF]
Fulgenzi CAM+7 more
europepmc +1 more source
Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]
Rao AM+6 more
europepmc +1 more source
Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy. [PDF]
Mezzadri L+14 more
europepmc +1 more source
Integrin α4β7 as a predictor of HIV acquisition: one thread in a complex tapestry. [PDF]
Omole TE, McKinnon LR.
europepmc +1 more source
Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus. [PDF]
Singh KP, Audsley J, Zhao W, Lewin SR.
europepmc +1 more source